United States v. Moon

513 F.3d 527, 75 Fed. R. Serv. 593, 2008 U.S. App. LEXIS 879, 2008 WL 140967
CourtCourt of Appeals for the Sixth Circuit
DecidedJanuary 16, 2008
Docket06-5581
StatusPublished
Cited by219 cases

This text of 513 F.3d 527 (United States v. Moon) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Moon, 513 F.3d 527, 75 Fed. R. Serv. 593, 2008 U.S. App. LEXIS 879, 2008 WL 140967 (6th Cir. 2008).

Opinion

OPINION

CLAY, Circuit Judge.

Defendant, Dr. Young Moon, appeals from her conviction and sentence entered by the United States District Court for the Middle District of Tennessee on April 25, 2006, for three counts of health care fraud in violation of 18 U.S.C. § 1347 and one count of making false statements regarding health care matters in violation of 18 U.S.C. § 1001. Specifically, Defendant appeals 1) the district court’s denial of her motion to dismiss count four of her indictment; 2) the district court’s denial of her motion to suppress evidence; 3) the reasonableness of her sentence; and 4) the *532 district court’s evidentiary rulings with respect to “summary evidence.” For the reasons that follow, we AFFIRM the district court’s judgment.

BACKGROUND

A. Factual Background

Defendant, Young Moon, was a medical doctor licensed by the State of Tennessee, specializing in oncology and hematology. Defendant operated a medical practice in Crossville, Tennessee where she treated patients with various forms of cancer. As part of her practice, Defendant contracted with the State of Tennessee to provide medical treatment to patients pursuant to a state and federally funded health benefit program for the uninsured known as “TennCare.” A number of providers participated in the program, including Blue Cross Blue Shield and Medicaid. Defendant routinely utilized chemotherapy medications such as Taxol, Camptosar and Pro-crit 1 in her treatment of cancer patients insured under the program. As a medical provider, Defendant was required to seek reimbursement for services, including medication, provided to patients under the insurance program.

In March of 2001, the Tennessee Bureau of Investigation (“TBI”) received a complaint from one of Defendant’s employees alleging that Defendant administered partial doses of chemotherapy medication while billing the insurance program for full doses. It was also alleged that the fraud was facilitated by the fact that Defendant mixed the cancer drugs she administered. The matter was referred to the Medicare Fraud Control Unit (“MFCU”) of TBI and a joint investigation was initiated between the United States Department of Health and Human Services Office of Inspector General (“HHS-OIG”) and TBI. After an initial investigation, agents from HHS-OIG and TBI conducted an “on site review” at Defendant’s office.

On January 9, 2002,10 agents associated with TBI, HHS-OIG and Blue Cross Blue Shield conducted an on-site review at Defendant’s office. The objective of the review was to “scan TennCare, Medicaid and Medicare patient records” and secondarily to “interview Dr. Moon and all of her employees.” (J.A. at 267) Members of the on-site review team were instructed that “attire will be business professional, no raid gear. All weapons, police paraphernalia shall be concealed.” (Id.) On the morning of the review, three agents arrived, unannounced, at Defendant’s office. The agents identified themselves, informed Defendant of a general complaint against her and requested permission to “scan” particular patient records. It is unclear whether Defendant was made aware of her right to withhold permission. After asking about the nature of the allegations and being told they were confidential, Defendant told agents it would be “fine” for them to scan the requested records and that agents could “scan whatever [they] needed to.” (J.A. at 341) Defendant also provided agents with a location where they could scan the requested files.

During the on-site review, agents requested an interview with Defendant regarding her billing practices. Defendant agreed to be interviewed “as long as it did not interrupt patient care.” (J.A. at 346) At one point, Defendant left the interview to attend to a patient. During the inter *533 view, Defendant stated that she always prescribed full doses of chemotherapy medication and never instructed her staff to give partial doses of medication.

B. Procedural Background

After further interviews with employees, reviewing bills submitted to relevant health insurance programs and consultation with experts regarding Defendant’s patient charts, the government sought an indictment for three counts of health care fraud.

1. Pretrial

On June 24, 2004, a grand jury sitting in the Middle District of Tennessee indicted Defendant on three counts of health care fraud in violation of 18 U.S.C. § 1347. Subsequently, Defendant moved to dismiss the indictment, alleging that it failed to include an interstate commerce element. The district court agreed and granted Defendant’s motion to dismiss. The government returned with a superseding indictment that suffered from a similar infirmity and was also dismissed. In response, the government sought and obtained a second superseding indictment that included the three original counts as well as an additional count alleging that Defendant made false statements to government agents in violation of 18 U.S.C. § 1001. Defendant challenged the addition of the fourth count of the indictment in a motion to dismiss, alleging prosecutorial vindictiveness. The district court denied Defendant’s motion and the fourth count of the indictment proceeded to trial.

Defendant also moved to suppress evidence of the two files obtained from her office and statements she made during the TBI/HHS-OIG on-site review, alleging they were obtained during a warrantless search in violation of the Fourth Amendment. After conducting a suppression hearing, the district court denied Defendant’s motion to suppress, finding that Defendant consented to the search of her office based on her verbal assent during the on-site review. Further, the district court found that Defendant’s contractual relationship with TennCare and other insurance programs provided a basis for voluntary consent and therefore the denied the motion to suppress.

2. Trial

Defendant went to trial on all four counts enumerated in the superseding indictment and the government was permitted to introduce evidence obtained as a result of its warrantless search of Defendant’s office. The trial lasted just over two weeks. During the trial, the jury heard testimony from former employees who recounted that Defendant had instructed them to “short” medication to patients. The government presented evidence in the form of testimony by Dr. Mace Rothenburg, an expert witness who testified that Defendant could not have administered the amount of medication she billed as the patient side effects were too mild. The government also presented evidence in the form of records from various pharmaceutical companies regarding Defendant’s purchases of chemotherapy medication.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Jeremy Cruz
976 F.3d 656 (Sixth Circuit, 2020)
United States v. Solon Tatum
Sixth Circuit, 2020
United States v. John Chambers
638 F. App'x 437 (Sixth Circuit, 2015)
United States v. Erik Thornton
621 F. App'x 324 (Sixth Circuit, 2015)
United States v. Angel Hernandez
611 F. App'x 261 (Sixth Circuit, 2015)
United States v. Jose Solano-Rosales
781 F.3d 345 (Sixth Circuit, 2015)
United States v. Victoria Wallace
600 F. App'x 322 (Sixth Circuit, 2015)
United States v. Sean Murphy
591 F. App'x 377 (Sixth Circuit, 2014)
United States v. Terrence Washington
575 F. App'x 560 (Sixth Circuit, 2014)
United States v. Steven Washington
565 F. App'x 458 (Sixth Circuit, 2014)
United States v. Marshawn Lytle
565 F. App'x 386 (Sixth Circuit, 2014)
United States v. Anthony Willoughby
742 F.3d 229 (Sixth Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
513 F.3d 527, 75 Fed. R. Serv. 593, 2008 U.S. App. LEXIS 879, 2008 WL 140967, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-moon-ca6-2008.